open access

Vol 50, No 1 (2018)
Original and clinical articles
Published online: 2018-03-31
Submitted: 2016-12-06
Accepted: 2018-02-17
Get Citation

Autoimmune anti-N-methyl-D-aspartate receptor encephalitis — the current state of knowledge based on a clinical case

Rafał Wójtowicz, Magdalena Krawiec, Piotr Orlicz
DOI: 10.5603/AIT.2018.0006
·
Pubmed: 29637991
·
Anaesthesiol Intensive Ther 2018;50(1):34-39.

open access

Vol 50, No 1 (2018)
Original and clinical articles
Published online: 2018-03-31
Submitted: 2016-12-06
Accepted: 2018-02-17

Abstract

The aim of this article is to conduct an overview of the current state of knowledge about patients presenting anti-Nmethyl- D-aspartate receptor encephalitis associated with neoplastic process, as well as diagnosis and treatment. This disease concerns mainly young women and correlates with ovarian teratoma. Most important problems seems to be the difficulties in making a proper diagnosis ensuing from the rarity of this syndrome, the period from the appearance the first symptoms to starting treatment and the correct handling of intensive care complications. There are only a few articles describing severe, complicated cases of this type of encephalitis, requiring treatment in an intensive care unit.

Abstract

The aim of this article is to conduct an overview of the current state of knowledge about patients presenting anti-Nmethyl- D-aspartate receptor encephalitis associated with neoplastic process, as well as diagnosis and treatment. This disease concerns mainly young women and correlates with ovarian teratoma. Most important problems seems to be the difficulties in making a proper diagnosis ensuing from the rarity of this syndrome, the period from the appearance the first symptoms to starting treatment and the correct handling of intensive care complications. There are only a few articles describing severe, complicated cases of this type of encephalitis, requiring treatment in an intensive care unit.
Get Citation

Keywords

autoimmune encephalitis; anti-N-methyl-D-aspartate receptor; ovarian teratoma; intensive care

About this article
Title

Autoimmune anti-N-methyl-D-aspartate receptor encephalitis — the current state of knowledge based on a clinical case

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 50, No 1 (2018)

Pages

34-39

Published online

2018-03-31

DOI

10.5603/AIT.2018.0006

Pubmed

29637991

Bibliographic record

Anaesthesiol Intensive Ther 2018;50(1):34-39.

Keywords

autoimmune encephalitis
anti-N-methyl-D-aspartate receptor
ovarian teratoma
intensive care

Authors

Rafał Wójtowicz
Magdalena Krawiec
Piotr Orlicz

References (9)
  1. Dalmau J, Tüzün E, Wu Hy, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1): 25–36.
  2. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1): 63–74.
  3. Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges. Ther Clin Risk Manag. 2014; 10: 517–525.
  4. Braverman JA, Marcus C, Garg R. Anti-NMDA-receptor encephalitis: A neuropsychiatric syndrome associated with ovarian teratoma. Gynecol Oncol Rep. 2015; 14: 1–3.
  5. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2): 157–165.
  6. Miya K, Takahashi Y, Mori H. Anti-NMDAR autoimmune encephalitis. Brain Dev. 2014; 36(8): 645–652.
  7. Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005; 58(4): 594–604.
  8. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12): 1091–1098.
  9. Thomas A, Rauschkolb P, Gresa-Arribas N, et al. Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurol. 2013; 70(12): 1566–1568.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl